Our specialists bring comprehensive expertise to lateral epicondylitis treatment
It is an essential part of the protocol that determines long-term success
10.1097/00004691-198804000-00003 J
Villalba et al., reported that doses up to 3000 mg/day did not produce serious adverse effects, but nausea and other gastrointestinal effects were reported [19]
The patients were diagnosed using the WHO criteria of post-COVID (long COVID) [52], namely: (a) individuals having a history of proven SARS-CoV-2 infection, (b) symptoms persisted beyond the acute phase of illness or manifested during recovery from acute COVID-19 infection, (c) symptoms lasted at least 2 months and are present 34 months after the onset of COVID-19, and (d) patients suffer from at least two symptoms that impair daily functioning including fatigue, memory or concentration problems, shortness of breath, chest pain, persistent cough, difficulty speaking, muscle aches, loss of smell or taste, affective symptoms, cognitive impairment, or fever [52]
.png?width=1638&height=869&name=H22025_GLP-1Guide_Graphics_glp-1%20strategy%20(1).png)
